Abbott plans to appeal $1.67B patent order (San Francisco Chronicle)
Abbott plans to appeal $1.67B patent order (San Francisco Chronicle)
Abbott Laboratories plans to appeal a jury’s $1.67 billion patent infringement ruling in a case involving two blockbuster drugs that treat rheumatoid arthritis and other immune disorders. Late Monday, a jury in the Eastern District of Texas found that Abbott’… Sponsored Topics: Abbott Laboratories – United States District Court for the Eastern District of Texas – Patent infringement – …
Categories: Patents Tags:
ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 … (Business Wire via Yahoo! Finance)
ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 … (Business Wire via Yahoo! Finance)
LOS ANGELES—-ImmunoCellular Therapeutics, Ltd. , a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today the issuance of a Japanese patent relating to the company’s monoclonal antibody therapeutics.
Categories: Patents Tags:
PubPat and ‘Patent Troll’ Make Odd Bedfellows (Law.com)
PubPat and ‘Patent Troll’ Make Odd Bedfellows (Law.com)
A “patent trolling” claim suing several big online names filed in Eastern District of Texas reveals that an attorney doing pro bono work for the Public Patent Foundation — which views software patents as an impediment to progress — isn’t fully in sync with the foundation’s mission.
Categories: Patents Tags: